Pacific Biosciences of California, Inc. (PACB)
USD 1.19
(-6.3%)
USD 1.19
(-6.3%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -277.28 Million USD | 6.56% |
| 2022 | -282.24 Million USD | -66.89% |
| 2021 | -250.75 Million USD | -74.02% |
| 2020 | 38.97 Million USD | -2.82% |
| 2019 | -71.57 Million USD | 0.62% |
| 2018 | -92.92 Million USD | -12.18% |
| 2017 | -80.82 Million USD | -32.71% |
| 2016 | -67.26 Million USD | -29.82% |
| 2015 | -25.09 Million USD | 12.35% |
| 2014 | -59.11 Million USD | 16.94% |
| 2013 | -71.16 Million USD | 18.84% |
| 2012 | -87.51 Million USD | 15.94% |
| 2011 | -103.28 Million USD | 22.77% |
| 2010 | -135 Million USD | -60.87% |
| 2009 | -83.96 Million USD | -100.77% |
| 2008 | -41.82 Million USD | -91.72% |
| 2007 | -21.81 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -69.41 Million USD | -2.09% |
| 2024 Q2 | -50.32 Million USD | -148.43% |
| 2023 Q2 | -62.27 Million USD | 13.67% |
| 2023 Q1 | -72.12 Million USD | 5.27% |
| 2023 Q4 | -86.38 Million USD | -33.85% |
| 2023 Q3 | -64.53 Million USD | -3.64% |
| 2023 FY | - USD | 6.56% |
| 2022 Q3 | -69.02 Million USD | 5.64% |
| 2022 Q2 | -73.15 Million USD | 7.25% |
| 2022 Q4 | -76.13 Million USD | -10.3% |
| 2022 FY | - USD | -66.89% |
| 2022 Q1 | -78.86 Million USD | -24.93% |
| 2021 FY | - USD | -74.02% |
| 2021 Q1 | -33.64 Million USD | -45.87% |
| 2021 Q2 | -37.41 Million USD | -11.19% |
| 2021 Q3 | -43.88 Million USD | -17.3% |
| 2021 Q4 | -63.12 Million USD | -43.86% |
| 2020 Q3 | -23.7 Million USD | -2.69% |
| 2020 Q2 | -23.08 Million USD | 28.9% |
| 2020 Q1 | -32.47 Million USD | -86.48% |
| 2020 FY | - USD | -2.82% |
| 2020 Q4 | -23.06 Million USD | 2.71% |
| 2019 FY | - USD | 0.62% |
| 2019 Q1 | -27.25 Million USD | 9.68% |
| 2019 Q2 | -21.52 Million USD | 21.01% |
| 2019 Q3 | -25.89 Million USD | -20.31% |
| 2019 Q4 | -17.41 Million USD | 32.76% |
| 2018 Q3 | -24.42 Million USD | -21.33% |
| 2018 Q1 | -21.79 Million USD | -8.23% |
| 2018 FY | - USD | -12.18% |
| 2018 Q4 | -30.17 Million USD | -23.51% |
| 2018 Q2 | -20.13 Million USD | 7.63% |
| 2017 Q1 | -20.17 Million USD | -17.74% |
| 2017 FY | - USD | -32.71% |
| 2017 Q4 | -20.13 Million USD | -2.77% |
| 2017 Q3 | -19.59 Million USD | 13.77% |
| 2017 Q2 | -22.72 Million USD | -12.61% |
| 2016 Q2 | -16.72 Million USD | 9.93% |
| 2016 Q3 | -15.67 Million USD | 6.31% |
| 2016 Q4 | -17.13 Million USD | -9.34% |
| 2016 FY | - USD | -29.82% |
| 2016 Q1 | -18.57 Million USD | -2820.28% |
| 2015 Q4 | -636 Thousand USD | 96.89% |
| 2015 Q1 | -18.56 Million USD | -7.08% |
| 2015 Q2 | -10.28 Million USD | 44.63% |
| 2015 Q3 | -20.48 Million USD | -99.19% |
| 2015 FY | - USD | 12.35% |
| 2014 Q3 | -7.44 Million USD | 59.6% |
| 2014 Q1 | -18.2 Million USD | -10.05% |
| 2014 FY | - USD | 16.94% |
| 2014 Q4 | -17.34 Million USD | -132.85% |
| 2014 Q2 | -18.43 Million USD | -1.29% |
| 2013 Q4 | -16.53 Million USD | 16.48% |
| 2013 Q3 | -19.8 Million USD | -0.02% |
| 2013 Q2 | -19.79 Million USD | -3.58% |
| 2013 Q1 | -19.11 Million USD | 11.89% |
| 2013 FY | - USD | 18.84% |
| 2012 Q1 | -27.44 Million USD | -30.37% |
| 2012 Q2 | -22.62 Million USD | 17.55% |
| 2012 Q4 | -21.69 Million USD | 3.28% |
| 2012 Q3 | -22.42 Million USD | 0.86% |
| 2012 FY | - USD | 15.94% |
| 2011 Q2 | -21.46 Million USD | 35.9% |
| 2011 Q1 | -33.48 Million USD | 4.69% |
| 2011 FY | - USD | 22.77% |
| 2011 Q4 | -21.04 Million USD | 25.23% |
| 2011 Q3 | -28.15 Million USD | -31.16% |
| 2010 Q3 | -39.25 Million USD | -24.9% |
| 2010 Q4 | -35.13 Million USD | 10.5% |
| 2010 Q1 | -29.21 Million USD | -11.39% |
| 2010 FY | - USD | -60.87% |
| 2010 Q2 | -31.42 Million USD | -7.58% |
| 2009 Q4 | -26.22 Million USD | -8.21% |
| 2009 FY | - USD | -100.77% |
| 2009 Q3 | -24.23 Million USD | 0.0% |
| 2008 FY | - USD | -91.72% |
| 2007 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -1955.921% |
| Cerus Corporation | -26.53 Million USD | -944.928% |
| OrthoPediatrics Corp. | -8.38 Million USD | -3208.46% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -2542.167% |
| Talis Biomedical Corporation | -66.04 Million USD | -319.838% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -1562.861% |
| Inogen, Inc. | -45.67 Million USD | -507.023% |
| Spectral AI, Inc. | -12.26 Million USD | -2161.311% |
| Nano-X Imaging Ltd. | -47.69 Million USD | -481.389% |
| CVRx, Inc. | -38.73 Million USD | -615.917% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -7759.467% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -2190.262% |
| Orthofix Medical Inc. | -86.98 Million USD | -218.77% |
| Venus Concept Inc. | -26.11 Million USD | -961.854% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | -457.116% |
| Bioventus Inc. | -23.07 Million USD | -1101.916% |
| BrainsWay Ltd. | -2.31 Million USD | -11898.356% |
| Envoy Medical, Inc. | -18.23 Million USD | -1420.353% |
| electroCore, Inc. | -17.76 Million USD | -1461.273% |
| IceCure Medical Ltd | -15.25 Million USD | -1717.885% |
| Lucid Diagnostics Inc. | -49.75 Million USD | -457.34% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -1545.035% |
| MaxCyte, Inc. | -44.12 Million USD | -528.358% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -2258.646% |
| Nexalin Technology, Inc. | -5.69 Million USD | -4771.398% |
| PAVmed Inc | -75.74 Million USD | -266.088% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | -415.797% |
| RxSight, Inc. | -41.03 Million USD | -575.688% |
| Sight Sciences, Inc. | -49.41 Million USD | -461.129% |
| SI-BONE, Inc. | -34.44 Million USD | -704.976% |
| TELA Bio, Inc. | -40.63 Million USD | -582.406% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | -375.629% |
| Treace Medical Concepts, Inc. | -39 Million USD | -610.834% |
| LivaNova PLC | 39.01 Million USD | 810.688% |
| 908 Devices Inc. | -34.02 Million USD | -714.936% |
| Alphatec Holdings, Inc. | -110.59 Million USD | -150.725% |
| Nemaura Medical Inc. | -7.28 Million USD | -3705.13% |
| NeuroPace, Inc. | -22.83 Million USD | -1114.338% |
| LENSAR, Inc. | -8.71 Million USD | -3082.029% |
| Apyx Medical Corporation | -18.11 Million USD | -1430.93% |
| Cutera, Inc. | -136.56 Million USD | -103.046% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -8103.609% |
| BioSig Technologies, Inc. | -28.15 Million USD | -884.981% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 11120.747% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -1221.082% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 172.29% |
| Axonics, Inc. | 7.77 Million USD | 3666.328% |
| Outset Medical, Inc. | -153.78 Million USD | -80.3% |
| IRIDEX Corporation | -7.44 Million USD | -3622.905% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | -182.667% |
| IRadimed Corporation | 20.8 Million USD | 1433.046% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -3339.37% |
| INVO Bioscience, Inc. | -6.88 Million USD | -3930.248% |
| Telesis Bio, Inc. | -40.49 Million USD | -584.765% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 856.011% |
| Varex Imaging Corporation | 67.2 Million USD | 512.622% |
| Quipt Home Medical Corp. | 44.07 Million USD | 729.171% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -2450.892% |
| Pulmonx Corporation | -55.09 Million USD | -403.307% |
| Dynatronics Corporation | -976 Thousand USD | -28309.808% |
| Modular Medical, Inc. | -17.1 Million USD | -1521.248% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -1814.27% |
| Semler Scientific, Inc. | 23.58 Million USD | 1275.472% |
| InMode Ltd. | 196.28 Million USD | 241.266% |
| Bruker Corporation | 599 Million USD | 146.291% |
| Cytosorbents Corporation | -28.81 Million USD | -862.423% |
| DexCom, Inc. | 916.7 Million USD | 130.248% |
| Align Technology, Inc. | 799.03 Million USD | 134.702% |
| Viveve Medical, Inc. | -20.61 Million USD | -1244.919% |
| ZimVie Inc. | 91.07 Million USD | 404.461% |
| Movano Inc. | -29.12 Million USD | -852.041% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -6190.428% |
| Nexalin Technology, Inc. | -5.69 Million USD | -4771.398% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -7759.467% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | -42.446% |
| Profound Medical Corp. | -27.12 Million USD | -922.296% |
| Insulet Corporation | 323.6 Million USD | 185.687% |
| enVVeno Medical Corporation | -25.01 Million USD | -1008.33% |
| Surmodics, Inc. | 1.18 Million USD | 23440.236% |
| iCAD, Inc. | -6.56 Million USD | -4123.641% |
| Nuwellis, Inc. | -16.35 Million USD | -1595.292% |
| Biotricity, Inc. | -8.82 Million USD | -3040.842% |
| iRhythm Technologies, Inc. | -96.86 Million USD | -186.265% |
| Aethlon Medical, Inc. | -11.84 Million USD | -2240.107% |
| InspireMD, Inc. | -20.91 Million USD | -1226.01% |
| PAVmed Inc. | -75.74 Million USD | -266.088% |
| BIOLASE, Inc. | -15.13 Million USD | -1731.574% |
| Beyond Air, Inc. | -59.03 Million USD | -369.723% |
| FONAR Corporation | 28.25 Million USD | 1081.475% |
| AxoGen, Inc. | -13.32 Million USD | -1980.447% |
| Vivani Medical, Inc. | -26.6 Million USD | -942.1% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 1229.872% |
| Inari Medical, Inc. | 7.11 Million USD | 3998.243% |
| UFP Technologies, Inc. | 72.74 Million USD | 481.18% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -8089.59% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -4404.26% |
| Tenon Medical, Inc. | -15.52 Million USD | -1685.69% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -1716.337% |
| Co-Diagnostics, Inc. | -41.47 Million USD | -568.54% |
| AdaptHealth Corp. | -171.09 Million USD | -62.067% |
| Sintx Technologies, Inc. | -6.6 Million USD | -4101.242% |
| NanoVibronix, Inc. | -3.43 Million USD | -7972.256% |
| Quanterix Corporation | -38.08 Million USD | -628.004% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -2450.892% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 924373.333% |
| TransMedics Group, Inc. | -7.6 Million USD | -3547.008% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -1173.981% |
| NeuroMetrix, Inc. | -7.09 Million USD | -3807.687% |
| Hyperfine, Inc. | -47.06 Million USD | -489.197% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | -375.555% |
| Biomerica, Inc. | -5.99 Million USD | -4526.765% |
| Bone Biologics Corporation | 479.57 Thousand USD | 57918.638% |
| AVITA Medical, Inc. | -39.56 Million USD | -600.778% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -2922.828% |
| Silk Road Medical, Inc | -45.08 Million USD | -515.089% |